AZ, BMS in monster merger talks

A record-breaking pharmaceutical merger may be in the making, with AstraZeneca and BMS reportedly in talks.

The companies have held discussions about a tie-up in recent months, according to a Sunday report by the Financial Times, citing people familiar with the matter.

Talks could yield a deal in the near term, those sources said, or it could be delayed or fall apart.

To see the whole article please log in.

Tiffany Walker

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here